BIOMAT Database Logo BIOMAT Database Logo

[Thrombocyte aggregation inhibitors during regional anesthesia]. 1999

J U Bleyl, and D M Albrecht
Klinik für Anästhesie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden.

UI MeSH Term Description Entries
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D000765 Anesthesia, Conduction Injection of an anesthetic to inhibit nerve transmission in a specific part of the body. Anesthesia, Regional,Conduction Anesthesia,Regional Anesthesia
D019637 Orthopedic Procedures Procedures used to treat and correct deformities, diseases, and injuries to the MUSCULOSKELETAL SYSTEM, its articulations, and associated structures. Orthopedic Surgery,Surgery, Orthopedic,Orthopedic Rehabilitation Surgery,Orthopedic Surgical Procedures,Orthopedic Procedure,Orthopedic Rehabilitation Surgeries,Orthopedic Surgeries,Orthopedic Surgical Procedure,Procedure, Orthopedic,Procedure, Orthopedic Surgical,Procedures, Orthopedic,Procedures, Orthopedic Surgical,Rehabilitation Surgeries, Orthopedic,Rehabilitation Surgery, Orthopedic,Surgeries, Orthopedic,Surgeries, Orthopedic Rehabilitation,Surgery, Orthopedic Rehabilitation,Surgical Procedure, Orthopedic,Surgical Procedures, Orthopedic

Related Publications

J U Bleyl, and D M Albrecht
[Inhibitors of thrombocyte aggregation].
January 1983, Farmakologiia i toksikologiia,
J U Bleyl, and D M Albrecht
Thrombocyte aggregation inhibitors are important.
January 2013, Deutsches Arzteblatt international,
J U Bleyl, and D M Albrecht
[Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy].
May 1984, Der Urologe. Ausg. A,
J U Bleyl, and D M Albrecht
[Thrombocyte aggregation inhibitors: what are the risks?].
October 2013, Praxis,
J U Bleyl, and D M Albrecht
[Use of thrombocyte aggregation inhibitors in cardiology].
December 1997, Der Internist,
J U Bleyl, and D M Albrecht
[Thrombocyte aggregation during adequate periodic hemodialysis].
January 1985, Khirurgiia,
J U Bleyl, and D M Albrecht
[Anticoagulants and thrombocyte aggregation inhibitors in cerebrovascular disorders].
October 1980, Die Medizinische Welt,
J U Bleyl, and D M Albrecht
[Effect of aggregation inhibitors on thrombocyte enzymatic activity].
January 1978, Farmakologiia i toksikologiia,
J U Bleyl, and D M Albrecht
[Prevention with thrombocyte aggregation inhibitors in cardiovascular indications].
May 1989, Der Internist,
J U Bleyl, and D M Albrecht
Concomitant use of thrombocyte aggregation inhibitors and proton pump inhibitors (PPIs).
March 2011, Zeitschrift fur Gastroenterologie,
Copied contents to your clipboard!